Fabian Finkelmeier

机构：Goethe University Frankfurt, Cardiovascular Center Bethanien, University Hospital Frankfurt, Frankfurt Cancer Institute · ORCID：0000-0001-8559-9910

发表论文 237 篇 · 总被引 6058 次 · h-index 35

代表论文

• A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC ‐D Index (2025 · Liver International · 被引 9)
• Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population (2025 · International Journal of Cancer · 被引 4)
• The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population (2025 · JNCI Journal of the National Cancer Institute · 被引 4)
• Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer (2025 · Journal of Hepatology · 被引 4)
• Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab (2025 · European Journal of Cancer · 被引 3)
• Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab (2025 · Journal for ImmunoTherapy of Cancer · 被引 3)